Co-Diagnostics, Inc. (CODX) Q3 2024 Earnings
CODX·Reported November 7, 2024·After market close
Co-Diagnostics, Inc. reported Q3 2024 revenue of $641.1K, beat analyst consensus of $375.0K by $266.1K. Diluted EPS came in at $-0.32, beat the $-0.33 consensus by $0.01.
Revenue
$641.1Kbeat by $266.1K
Consensus: $375.0KDiluted EPS
$-0.32beat by $0.01
Consensus: $-0.33
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Co-Diagnostics, Inc. 's Q3 2024 earnings report.
Co-Diagnostics, Inc. (CODX) reported Q3 2024 earnings on November 7, 2024 after market close.
Co-Diagnostics, Inc. reported revenue of $641.1K and diluted EPS of $-0.32 for Q3 2024.
Revenue beat the consensus estimate of $375.0K by $266.1K. EPS beat the consensus estimate of $-0.33 by $0.01.
You can read the 10-Q periodic report (0001493152-24-044008) directly on SEC EDGAR. The filing index links above go to sec.gov.